The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Open accessAbstract
The role of advanced glycation end products (AGEs) in promoting and/or exacerbating metabolic dysregulation is being increasingly recognized. AGEs are formed when reducing sugars nonenzymatically bind to proteins or lipids, a process that is enhanced by hyperglycemic and hyperlipidemic environments characteristic of numerous metabolic disorders including obesity, diabetes, and its complications. In this mini-review, we put forth the notion that AGEs span the spectrum from cause to consequence of insulin resistance and diabetes, and represent a “common soil” underlying the pathophysiology of these metabolic disorders. Collectively, the surveyed literature suggests that AGEs, both those that form endogenously as well as exogenous AGEs derived from environmental factors such as pollution, smoking, and “Western”-style diets, contribute to the pathogenesis of obesity and diabetes. Specifically, AGE accumulation in key metabolically relevant organs induces insulin resistance, inflammation, and oxidative stress, which in turn provide substrates for excess AGE formation, thus creating a feed-forward–fueled pathological loop mediating metabolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716
Cai, W., He, J. C., Zhu, L., Lu, C., & Vlassara, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600362103 · Cited by 163
Parikh, M., Chung, M., Sheth, S., McMacken, M., Zahra, T., Saunders, J. K., Ude-Welcome, A., Dunn, V., Ogedegbe, G., Schmidt, A. M., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000919 · Cited by 123
Self-citationTahara, N., Yamagishi, S., Matsui, T., Takeuchi, M., Nitta, Y., Kodama, N., Mizoguchi, M., & Imaizumi, T. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00177.x · Cited by 116
Serum advanced glycation end products (AGEs) are associated with insulin resistance
Tan, K. C. B., Shiu, S. W. M., Wong, Y., & Tam, X. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1188 · Cited by 111
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Alexandraki, K., & Panidis, D. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02693.x · Cited by 69
Cited by
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
Hajishengallis, G., & Chavakis, T. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00488-6 · Cited by 1,871
The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction
An, Y., Xu, B.-T., Wan, S.-R., Ma, X.-M., Long, Y., Xu, Y., & Jiang, Z.-Z. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01965-7 · Cited by 396
Shen, C.-Y., Lu, C.-H., Wu, C.-H., Li, K.-J., Kuo, Y.-M., Hsieh, S.-C., & Yu, C.-L. (2020) · Molecules · doi:10.3390/molecules25235591 · Cited by 301
Metadata
- Authors
- Ruiz, H. H., Ramasamy, R., & Schmidt, A. M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2019-10-22
- Volume
- 161
- Issue
- 1
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2981709735
- Cited by
- 184
- References
- 9
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.